LXRX · Lexicon Pharmaceuticals, Inc.

$2.32 -0.02 (-0.85%) At close · Aug 14

Market Cap

$1.03B

444.96M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael S. Exton	Chief Executive Officer and Director	$650,576	$483,822	$1,049,304	$1,355,231	—	$15,020	$3,553,953

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Former Chief Executive Officer and Director	$438,757	—	$1,656,403	$1,358,106	—	$59,507	$3,512,773
Michael S. Exton	Chief Executive Officer and Director	$303,726	$222,600	—	$2,308,770	—	$493	$2,835,589
Jeffrey Wade	Former President and Chief Financial Officer	$485,525	—	$675,788	$977,247	—	$425,714	$2,564,274
Thomas A. Garner	Former Senior Vice President and Chief Commercial Officer	$471,032	—	$488,330	$400,387	—	$627,676	$1,987,425
Craig B. Granowitz	M.D., Ph.D. Senior Vice President and Chief Medical Officer	$501,686	$199,373	$478,762	$392,543	—	$16,019	$1,588,383
Brian T. Crum	Senior Vice President and	$473,503	$125,442	$447,544	$366,947	—	$17,171	$1,430,607
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$457,802	$123,372	$440,170	$360,901	—	$14,278	$1,396,523
Kristen L. Alexander	Vice President, Finance and Accounting	$295,588	$67,409	$128,269	$105,169	—	$16,810	$613,245

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Former Chief Executive Officer and Director	$740,846	$386,233	$877,595	$2,090,227	—	$15,220	$4,110,121
Jeffrey Wade	Former President and Chief Financial Officer	$535,729	$200,097	$358,036	$852,786	—	$16,220	$1,962,868
Craig B. Granowitz	M.D., Ph.D. Senior Vice President and Chief Medical Officer	$487,628	$149,650	$260,909	$621,431	—	$15,205	$1,534,823
Brian T. Crum	Senior Vice President and	$457,936	$122,404	$243,899	$580,897	—	$16,139	$1,421,275
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$442,787	$120,385	$239,865	$571,309	—	$13,790	$1,388,136
Thomas A. Garner	Former Senior Vice President and Chief Commercial Officer	$214,564	$276,119	—	$219,003	—	$568	$710,254
Kristen L. Alexander	Vice President, Finance and Accounting	$285,359	$67,463	$116,105	$138,269	—	$15,788	$622,984

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Former Chief Executive Officer and Director	$709,637	$502,005	$877,088	$2,067,992	—	$13,220	$4,169,942
Jeffrey Wade	Former President and Chief Financial Officer	$513,354	$260,075	$357,824	$843,690	—	$15,220	$1,990,163
Craig B. Granowitz	M.D., Ph.D. Senior Vice President and Chief Medical Officer	$467,459	$189,520	$268,000	$631,881	—	$14,162	$1,571,022
Kenneth B. Kassler-Taub	Senior Vice President, Regulatory and Quality Assurance	$424,148	$151,778	$264,544	$623,733	—	$12,772	$1,476,975
General Counsel	—	$438,989	$155,015	$250,528	$590,686	—	$15,099	$1,450,317
Brian T. Crum	Senior Vice President and	$438,989	$155,015	$250,528	$590,686	—	$15,099	$1,450,317
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$426,169	$152,457	$246,400	$580,928	—	$12,775	$1,418,729
Kristen L. Alexander	Vice President, Finance and Accounting	$269,867	$82,044	$101,920	$120,164	—	$14,756	$588,751

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Chief Executive Officer and Director	$688,825	$438,645	$838,000	$1,946,000	—	$12,620	$3,924,090
Jeffrey Wade	President and Chief Financial Officer	$476,319	$227,250	$280,981	$652,559	—	$14,574	$1,651,683
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$414,024	$148,016	$225,673	$523,993	—	$12,158	$1,323,864
Brian T. Crum	Senior Vice President and	$407,609	$135,450	$219,975	$510,890	—	$14,429	$1,288,353
General Counsel	—	$407,609	$135,450	$219,975	$510,890	—	$14,429	$1,288,353
Craig B. Granowitz	M.D., Ph.D. Senior Vice President and Chief Medical Officer	$188,322	$73,175	—	$686,405	—	$646	$948,548
Kenneth B. Kassler-Taub	Senior Vice President, Regulatory and Quality Assurance	$392,646	$152,807	$178,159	$206,860	—	$12,127	$942,599

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Chief Executive Officer and Director	$668,620	$473,188	$840,376	$1,866,067	—	$12,420	$3,860,671
Pablo Lapuerta	Former Executive Vice President and Chief Medical Officer	$317,070	—	$272,777	$605,689	—	$667,349	$1,862,885
Jeffrey Wade	President and Chief Financial Officer	$456,372	$184,967	$302,534	$671,790	—	$13,839	$1,629,502
Praveen Tyle	Executive Vice President, Research and Development	$483,159	$196,755	$284,892	$632,615	—	$12,400	$1,609,821
Alexander A. Santini	Former Executive Vice President and Chief Commercial Officer	$315,075	—	$233,554	$518,641	—	$286,765	$1,354,036
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$403,824	$144,406	$231,369	$513,765	—	$11,945	$1,305,309
Brian T. Crum	Senior Vice President and	$387,747	$136,986	$208,828	$463,687	—	$12,192	$1,209,201
General Counsel	—	$387,747	$136,986	$208,828	$463,687	—	$12,192	$1,209,201
Kenneth B. Kassler-Taub	Senior Vice President, Regulatory and Quality Assurance	$375,060	$116,196	$181,156	$201,309	—	$12,018	$704,569

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	Chief Executive Officer and Director	$649,196	$459,406	$1,228,802	$1,520,667	—	$12,220	$3,870,291
Praveen Tyle	Executive Vice President, Research and Development	$475,048	$192,426	$486,765	$509,571	—	$12,179	$1,675,989
Jeffrey Wade	President and Chief Financial Officer	$444,431	$181,817	$491,488	$484,471	—	$12,116	$1,614,323
Pablo Lapuerta	Former Executive Vice President and Chief Medical Officer	$410,487	$148,387	$438,209	$449,433	—	$12,046	$1,458,562
Alexander A. Santini	Former Executive Vice President and Chief Commercial Officer	$409,459	$166,768	$428,766	$437,777	—	$12,047	$1,454,817
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$393,270	$140,542	$421,336	$428,562	—	$11,730	$1,395,440
General Counsel	—	$369,287	$133,072	$246,825	$171,746	—	$11,955	$932,885
Brian T. Crum	Vice President and	$369,287	$133,072	$246,825	$171,746	—	$11,955	$932,885

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	President, Chief Executive Officer and Director	$634,159	$402,399	$690,587	$1,384,268	—	$12,020	$3,123,433
Praveen Tyle	Executive Vice President, Research and Development	$464,600	$160,903	$285,672	$541,775	—	$11,956	$1,464,906
Jeffrey Wade	Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer	$436,644	$158,450	$280,630	$520,384	—	$11,895	$1,408,003
Pablo Lapuerta	Former Executive Vice President and Chief Medical Officer	$401,482	$121,646	$251,701	$473,154	—	$11,827	$1,259,810
Alexander A. Santini	Former Executive Vice President and Chief Commercial Officer	$399,719	$102,501	$248,568	$470,603	—	$11,828	$1,233,219
Alan J. Main	Executive Vice President, Innovation and Chemical Sciences	$384,656	$123,704	$243,673	$457,515	—	$11,799	$1,221,347
General Counsel	—	$350,698	$116,857	$150,325	$150,717	—	$11,716	$780,313

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Lonnel Coats	President, Chief Executive Officer and Director	$618,259	$392,585	$309,738	$879,785	—	$11,820	$2,212,187
Praveen Tyle	Executive Vice President, Research and Development	$454,383	$165,645	$172,702	$490,867	—	$11,736	$1,295,333
Jeffrey Wade	Executive Vice President, Corporate and Administrative Affairs and Chief Financial Officer	$427,038	$154,963	$161,584	$459,175	—	$11,675	$1,214,435
Pablo Lapuerta	Executive Vice President and Chief Medical Officer	$394,604	$100,233	$149,310	$424,303	—	$11,609	$1,080,059
Alexander A. Santini	Executive Vice President and Chief Commercial Officer	$393,830	$93,313	$149,743	$425,329	—	$11,611	$1,073,826

Executive changes

Person	Role	Change	Effective	Filed
Scott M. Coiante	senior vice president and chief financial officer	Appointed	2025-01-02	2025-01-02
Ivan H. Cheung	member of our board of directors	Appointed	2024-12-02	2024-11-20
Robert J. Lefkowitz, M.D.	member of our board of directors	Retired	2024-12-02	2024-11-20
Kristen L. Alexander	principal financial officer	Appointed	2024-09-30	2024-09-16
Jeffrey L. Wade	president and chief operating officer	Terminated	2024-09-30	2024-09-16
Michael Exton, Ph.D.	member of our board of directors	Appointed	2024-07-08	2024-07-08
Michael Exton, Ph.D.	chief executive officer (in which capacity he will function as our principal executive officer)	Appointed	2024-07-08	2024-07-08
Lonnel Coats	member of our board of directors	Retired	2024-07-07	2024-04-29
Lonnel Coats	chief executive officer	Retired	2024-07-07	2024-04-29
Alan S. Nies, M.D.	board of directors	Retired	2023-10-26	2023-10-11
Diane E. Sullivan	member of our board of directors	Appointed	2023-07-27	2023-07-31
Frank P. Palantoni	board of directors	Resigned	2023-07-27	2023-07-24

Key facts CIK 1062822 CUSIP 528872302 13F (30d) 150 filings 149 filers Visit website Investor relations